Corporate Overview
Medical Nutrition USA, Inc. develops and distributes products for the nutritionally-at-risk who are under medical supervision. Its products are used primarily in long-term care facilities, hospitals, dialysis and bariatric surgery clinics. The Company sells its branded products directly to distributors who resell the products to end users and private label products to others who sell these products to customers. Medical Nutrition USA, Inc. is headquartered in Englewood, New Jersey.
Prominent in the field for over 40 years, Founder and Chief Scientific Officer Arnold Gans has been dedicated to formulating nutritional protein supplements. Mr. Gans has used his expertise in the nutritional field to develop demonstrably superior and cost-effective products with proven health benefits.
Since 2003, Medical Nutrition USA, Inc. has been improving clinical outcomes through evidence-based research on the effects of targeted nutritional intervention. Our uniquely engineered liquids provide nutritional support in the most concentrated, convenient and bio-available form. Minimal serving sizes with maximum potency and digestibility allow for needed supplementation to be administered in the least disruptive and most easily consumed and monitored manner. Our products provide consistent outcomes with unsurpassed ease of administration, improved compliance and resident/patient acceptance.
Through observational studies, clinical experience and controlled trials, we and our team of medical advisors have detailed positive clinical outcomes on a wide range of common disorders, including: pressure ulcers, unintended weight loss, sarcopenia, cachexia (muscle wasting), surgical recovery, protein energy malnutrition, hypoalbuminemia among end stage renal disease patients on dialysis, and management of chronic bowel irregularity.
Industry Overview
The market served by MDNU is attractive
in many ways. Nutritional supplements
for healthcare institutions have
sustained 12% per annum core growth
resulting from “the aging of
America” and advances in nutritional
science. Market growth recently has
been accelerating due to heightened
third party payor inducements to
avoid flawed nutritional care for
the aged and those nutritionally-at-risk.” Furthermore,
aided by significant barriers to
entry in the industry, MDNU has been
able to maintain and gain share vs.
the competition.
Strategies for Growth
- Develop cost-effective products
with proven clinical outcomes that
replace ineffective therapies
- Expand and penetrate institutional
markets by increasing sales force
and network of distributors
- 4 Regional and 18 Area Managers
- Inside sales and telemarketing
- Create new categories through development
and introduction of complementary
products e.g. UTI-Stat
- Expand distribution to retail market
- Aggressive marketing
- Clinical advisors and Speakers
Bureau
- National advertising
- Accredited CE Programs
- International distribution
Why Invest in MDNU
- Rapid sales growth through greater
institutional distribution, retail
expansion and international distribution
- Proven marketing strategy
- Strong demographics supporting
core market
- Product efficacy based on clinical
studies
- Majority of market remains untapped
- Financially strong and debt free
- Ability to create new categories
through development and introduction
of complementary products
